In this paper, we examine:
• Why the life sciences industry must emphasize quality over mere compliance.
• Current and emerging guidelines and regulations aimed at improving medical device and pharmaceutical product quality.
• The challenges posed to mid-sized and emerging life sciences manufacturers.
• Why companies should act quickly to align to these upcoming guidelines and regulations.